Zhihui Liu

Title: Zhihui Liu: Innovator in Pharmaceutical Formulation

Introduction

Zhihui Liu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical formulation, particularly in the development of injectable medications. His innovative work focuses on improving the stability and efficacy of drug formulations.

Latest Patents

Zhihui Liu holds a patent for an "Aripiprazole injectable suspension formulation having prolonged shelf life." This invention pertains to a pharmaceutical formulation that enhances the shelf life of aripiprazole, a medication used in treating schizophrenia and related diseases. The formulation not only improves the stability of the drug but also provides methods for its effective use in clinical settings.

Career Highlights

Liu is associated with Nanjing Noratech Pharmaceuticals Co., Ltd., where he applies his expertise in pharmaceutical sciences. His work has been instrumental in advancing the company's product offerings and enhancing patient care through innovative drug formulations.

Collaborations

Zhihui Liu collaborates with talented professionals in his field, including Yunzhe Sun and Qi Peng. These partnerships foster a creative environment that drives innovation and leads to the development of groundbreaking pharmaceutical solutions.

Conclusion

Zhihui Liu's contributions to pharmaceutical formulation exemplify the impact of innovation in healthcare. His work not only addresses critical needs in medication stability but also enhances treatment options for patients suffering from schizophrenia.